An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston |
Tag: Johnson & Johnson
Wall Street heads into week ahead on edge, bracing for earnings, data
How corporate America is handling sticky inflation and the prospect of higher interest rates will be top of mind for investors in
Microsoft, Salesforce woo skeptical CFOs on new generative AI spending
Optimism around the transformational opportunity of generative artificial intelligence continues to grow. As Nvidia CEO Jensen Huang recently told CNBC’s Jim Cramer
Amazon and Dell are benefiting the most from Nvidia partnership
Recently, I read a terrific little book about Abraham Lincoln, called “Lincoln Reconsidered,” by Professor David Herbert Donald, and the fundamental premise
Jim Cramer defends Elon Musk’s use of ketamine for depression
CNBC’s Jim Cramer said Tuesday that Elon Musk’s disclosure that he takes prescription ketamine for depression was courageous and “saved a lot
Nvidia and Johnson & Johnson to build AI applications for surgery
The New York Stock Exchange welcomes Johnson & Johnson. NYSE Johnson & Johnson on Monday announced it is working with Nvidia to
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers
Merck, J&J CEOs agree to testify in Senate hearing on drug prices
US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare
Johnson & Johnson (JNJ) earnings Q4 2023
The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket |
Stock market today: Live updates
A trader works on the floor at the New York Stock Exchange on Dec. 4, 2023. Brendan Mcdermid | Reuters U.S. stock
No More Posts Available.
No more pages to load.